Literature DB >> 16431058

Lethal self administration of propofol (Diprivan). A case report and review of the literature.

Elena F Kranioti1, Anna Mavroforou, Panagiotis Mylonakis, Manolis Michalodimitrakis.   

Abstract

The death of a female anaesthesiologist is reported. Although the situation at the scene indicated propofol overdose-related death, self-administration of such high doses of propofol was unlikely, given the pharmacological properties of this drug. The analysis of the situation at the scene and the toxicological analysis in which the blood and liver propofol concentrations were 2.40microg/ml and 0.56microg/g, respectively, supported the conclusion that the death was a consequence of propofol self-administration at therapeutic doses from a person who used the drug on chronic basis seeking to its euphoric effects. However, because the toxic concentrations of propofol in non-intubated patients may be different from those intubated and fully supported in the operating room or in the intensive care unit, a mere interpretation of the blood and tissue concentrations of propofol in the toxicological analysis can confirm the drug intake but it may be of limited diagnostic significance without taking into account this difference.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431058     DOI: 10.1016/j.forsciint.2005.12.027

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  10 in total

1.  [Life-threatening fentanyl and propofol addiction: interview with a survivor].

Authors:  C Maier; J Leclerc-Springer
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

2.  Upregulation of DeltaFosB by propofol in rat nucleus accumbens.

Authors:  Ming Xiong; Jingyuan Li; Jiang H Ye; Chunxiang Zhang
Journal:  Anesth Analg       Date:  2011-06-03       Impact factor: 5.108

3.  Propofol use for sedation or sedation for propofol use?

Authors:  Duk-Kyung Kim
Journal:  J Anesth       Date:  2011-11-26       Impact factor: 2.078

Review 4.  Clinical effects and lethal and forensic aspects of propofol.

Authors:  Richard J Levy
Journal:  J Forensic Sci       Date:  2010-10-15       Impact factor: 1.832

5.  Circumstantial and toxicological features of deaths from self-administered intravenous anesthetic/narcotic agents.

Authors:  Takahito Hayashi; Claas Buschmann; Benno Riesselmann; Sonja Roscher; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2012-08-28       Impact factor: 2.007

6.  Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients.

Authors:  Thorsten Brechmann; Christoph Maier; Miriam Kaisler; Jan Vollert; Wolff Schmiegel; Svetlana Pak; Norbert Scherbaum; Fred Rist; Andrea Riphaus
Journal:  United European Gastroenterol J       Date:  2017-10-04       Impact factor: 4.623

7.  Abuse potential assessment of propofol by its subjective effects after sedation.

Authors:  Aysu Hayriye Tezcan; Dilsen Hatice Ornek; Onur Ozlu; Mustafa Baydar; Nurcan Yavuz; Nihal Gokbulut Ozaslan; Kevser Dilek; Aylin Keske
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

8.  An outbreak of HIV infection among people who inject drugs linked to injection of propofol in Taiwan.

Authors:  Yu-Ching Huang; Yen-Fang Huang; Min-Hau Lin; Jyh-Yuan Yang; Yu-Hsin Liao; Hsiu-Yun Lo; Carl Latkin; Kenrad E Nelson
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

9.  Is propofol safe when administered to cirrhotic patients during sedative endoscopy?

Authors:  Sang Jun Suh; Hyung Joon Yim; Eileen L Yoon; Beom Jae Lee; Jong Jin Hyun; Sung Woo Jung; Ja Seol Koo; Ji Hoon Kim; Kyung Jin Kim; Rok Son Choung; Yeon Seok Seo; Jong Eun Yeon; Soon Ho Um; Kwan Soo Byun; Sang Woo Lee; Jai Hyun Choi; Ho Sang Ryu
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

Review 10.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.